Literature DB >> 7034838

The present status of electroconvulsive therapy.

R E Kendell.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7034838     DOI: 10.1192/bjp.139.4.265

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  17 in total

1.  Electroconvulsive therapy.

Authors:  C E Taylar
Journal:  Can Fam Physician       Date:  1984-02       Impact factor: 3.275

2.  Depression resistant to tricyclic antidepressants.

Authors:  P J Cowen
Journal:  BMJ       Date:  1988-08-13

Review 3.  Fifty years of electroconvulsive therapy.

Authors:  A Linington; B Harris
Journal:  BMJ       Date:  1988-11-26

4.  INTRAOCULAR TENSION VARIATIONS WITH ELECTROCONVULSIVE THERAPY.

Authors:  S Chaudhury; S S Rajuria; R S Mahar
Journal:  Med J Armed Forces India       Date:  2017-06-27

5.  Regional neurotransmitter responses after acute and chronic electroconvulsive shock.

Authors:  P Glue; M J Costello; A Pert; A Mele; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity.

Authors:  N R Hoyle; R T Pratt; D G Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

7.  Electroconvulsive therapy: physiological and anaesthetic considerations.

Authors:  R J Marks
Journal:  Can Anaesth Soc J       Date:  1984-09

8.  Strategies for the drug treatment of depression.

Authors:  A J Cooper; R V Magnus
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

9.  Response to first ect in depression : a predictor of outcome.

Authors:  N Gupta; A Avasthi; P Kulhara
Journal:  Indian J Psychiatry       Date:  1998-10       Impact factor: 1.759

10.  5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.

Authors:  G M Goodwin; A R Green; P Johnson
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.